TELA Bio (TELA) Income Statement: Revenue & Earnings

TELA Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

TELA Bio, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	69.30	58.45	41.42	29.46	18.21
Cost of Revenue	22.43	18.34	13.57	10.35	6.68
Gross Profit	46.87	40.11	27.85	19.12	11.54
Operating Expenses
Research & Development	8.81	9.62	8.94	6.74	4.26
Selling, General & Administrative	79.37	74.57	57.11	41.52	32.25
Operating Expenses	88.56	84.19	66.86	48.57	36.81
Operating Income	-41.70	-44.08	-39.01	-29.45	-25.28
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	-5.29	5.22	-4.05	-3.60	-3.56
Other Income/Expense	1.42	2.63	-0.01	-0.23	0.05
Income
Income Before Tax	-37.99	-46.66	-44.30	-33.28	-28.79
Income Tax Expense	-0.14	0.00	0.00	0.00	0.00
Net Income	-37.84	-46.66	-44.30	-33.28	-28.79
Net Income - Continuous Operations	-37.84	-46.66	-44.30	-33.28	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-40.68	-40.63	-37.82	-28.92	-24.75
EBIT	-41.70	-41.44	-39.01	-29.45	-25.28
Depreciation & Amortization	1.01	0.81	1.19	0.54	0.53
Earnings Per Share
Basic EPS	-1.00	-2.00	-3.00	-2.00	-2.00
Diluted EPS	-1.00	-2.00	-3.00	-2.00	-2.00
Basic Shares Outstanding	28.53	22.87	16.27	14.47	12.93
Diluted Shares Outstanding	28.53	22.87	16.27	14.47	12.93